IGNT.PK

[greengiant]

Ingen, Inc. (OTC.PK: IGNT)
Ingen Technologies brings over 20 years of experience and dedication to the design and support of medical devices, Ingen has helped many medical professionals meet clinical and economic objectives.
Ingen has developed medical products that provide a valuable benefit to the patient and cost savings to the insurance companies, Medicare and essentially the tax payer. The medical products provide a focus for the ever-increasing elderly population. These products are superior to any of our competition and they allow for effective medical product availability to seniors.
Ingen's Mission: Their Commitment to Customers
Ingen is committed to meeting the needs of their customers through ongoing product innovation and support. Ingen distributes its products through a national distributor network domestically and in Canada, Asia and European Communities. Ingen's commitment to customers continues beyond the sale of their product.
The Beginning
Ingen, originally a privately owned company founded for the purpose of providing medical solutions for our growing healthcare market, is now a publicly traded company and growing medical device manufacturer. In 1999, Ingen founders invested several millions of dollars in the research and development of state-of-the-art respiratory monitoring devices, with a focus on helping patients and preventing unnecessary costs to the healthcare system. With multiple patents, FDA classification and certifications, Ingen is the largest manufacturer of gravity-independent in-line oxygen flow meters, meeting the demand of the growing patient population and service providers. Their products are manufactured in the USA.
Their Capabilities
The company is proud of their capabilities in gas flow-meter technology and wireless digital data transfer of gas flow rate processing. Ingen is the first company to patent and develop transducers that detect oxygen flow rate and provide data transfer. This has revolutionized the oxygen therapy market providing user friendly solutions in monitoring oxygen levels and oxygen delivery systems.
Ingen Technologies, Inc. introduces Oxyview®, the World's First Patient In-Line Oxygen Flow-Meter. Another innovative respiratory product manufactured in the USA by Ingen Technologies; providing more confidence and assurance to patients using oxygen. Oxyview® is reusable, requires no batteries, works all the time in any position with all liquid or gas O2 systems, and easily installs anywhere below the cannula nearest the patient where oxygen flow matters the most. Oxygen suppliers and patients will appreciate that Oxyview® prevents many unnecessary service calls.
Oxygen is an element, a gas, and a drug that can help people who have certain lung diseases.  The cells in the body get their energy from the interaction of oxygen with food.  The energy produced is used to do everything from breathing, to carrying out bodily functions, to going to the grocery store.  Some lung diseases, such as emphysema and sarcoidosis, reduce lung function to the extent that supplemental oxygen is needed to continue normal bodily function.  For many people with end stage lung disease, supplemental oxygen allows their bodies to get the oxygen that they need and may also help them be more active.
To say that we need oxygen to exist is as obvious as saying we need water. But as we all know, water can also be a destructive force. The key, of course, is having the right amount in the right place at the right time. That is just as important for oxygen, especially for those who require supplementary oxygen.
An essential component to this remedy is a flow meter to ensure that the right amount of oxygen is being delivered, and just as important that it is being delivered at all. Regardless of the use of an oxymeter to measure blood gas, Oxyview® provides vital information related to functionality of the cannula and all of the oxygen equipment. If something is wrong with the cannula or equipment, the Oxyview® will show you immediately. This is usually achieved by a pneumatic flow meter, but most
that are currently on the market are expensive, attach at the tank, and are gravity-operated, which means that they only work in the vertical position with or without the cannula attached at the delivery source. In contrast, Oxyview® attaches to the cannula close to the patient— where oxygen matters the most. Oxyview® is 97 percent accurate and works hands-free in any position, whereas the conventional flow meter is less than 80 percent accurate and does not attach to the cannula.
Gravity-operated devices are also inconvenient for the patient since they must keep the tanks within sight to check the gauges for flow rate. If the tank is tilted even slightly, the gravity-operated flow meter becomes even more inaccurate and may cease functioning because friction is too great. One alternative is a digital flow meter, but these may be prohibitively expensive.
That's why the Oxyview® flow meter (Ingen Technologies, Inc., Yucaipa, CA) is a significant advance in the technology. When first launched in November 2007, it represented a new generation of pneumatic real-time safety devices. It has some notable features: accurate to within + 3% and versatile enough to work with all respiratory equipment—CP AP, concentrators, liquid and gas cylinders, on-demand conservers and more. It is not gravity-dependent and so can be placed at any point in the tubing, even by the patients themselves. Having the device close by for easy viewing allows the patient assurance and confidence, knowing that there is a flow of oxygen at the correct level. They are also able to quickly see if the regulator or concentrator is not working properly.

[STOCKSEEKER]

Check out IGNTs news. This is some big news for the company. I am expecting some record high volume in the am with some real nice gains. This is an awesome time to load up on this one before it explodes in the am. Stock has been trading with some great volume the past few days trading days with no news at all. If you have been watchin this one like I suggested you would have noticed theres a few shorts on this one but Imo there is no way in hell there holdin this one back in the am. I also think were going to have a great week. Im thinkn ten bagger, but that is just my excited opinion. Here is the latest news..

 

YUCAIPA, Calif., June 11, 2010 (GLOBE NEWSWIRE) -- Ingen Technologies, Inc. (Pink Sheets:IGNT - News), a medical device manufacturer with an emerging new medical product line for the respiratory market worth an estimated $4 billion in the U.S. and $8 billion globally, today announced the following information updating shareholders on company progress:

 

During Ingen's fourth quarter the company focused aggressively on its marketing and advertising saturation campaign. This included being a featured product at the Las Vegas MedTrade Spring conference. The company has also published full color advertisements in major medical publications, such as COPD Digest, AARC Times, Everything Respiratory, LUNG Magazine, Today's Senior Magazine, and many others. Management is focused and dedicated to branding the company's product lines and increasing sales and distribution. Ingen is also scheduled for several major market conferences during the first quarter-2010, including Alpha-1 in Orlando, MedTrade in Georgia and AARC.

 

During the fourth quarter Ingen filed two more provisional patents; one for its new IngenThermo drug product, and the other for its new cannula technology. The IngenThermo uses polymer-crystal technology to keep insulin and other glass vile drugs cool and safe. Ingen's engineering team is working on the tooling and molds to manufacture this new product using medical-grade polycarbonate as an insulating material, along with polymer-crystals. We expect to deliver this product during the first quarter-2010. The new cannula technology involves the use of special materials that are embedded within the PVC of the nasal cannula. As oxygen flows, it will change the color of the cannula which would indicate a specific flow rate. This technology will complement Ingen's Oxyview technology and secure the company's position as maintaining the gold-standard within the respiratory oxygen therapy market.

 

The fourth quarter ended May 31, 2010 has proven to drive Ingen in the right direction with increased sales, increased assets and a decrease in debts. Specifically, sales were 80% higher in the fourth quarter as compared to the third quarter. Total sales for fourth quarter were approximately $10,000, as compared to $5,576 ending in the third quarter. The company was able to decrease the $4.5M note to its major note holders to $1.9M. It is expected that the company will fully reduce the balance of the notes over the first quarter of 2010. The company has a pending purchase order from a major distributor for $100,000 expected to ship in July with new inventory. Another expected purchase order from one of our OEM partners amounts to $120,000. Further, the company's government services consultant is expected to close $1.4M in government sales during the first and second quarters of 2010, while GSA evaluates the company's application submitted in September 2009. GSA usually takes 6-12 months to complete and approve applications. The company expects to reach its projected sales of $11M by end of our 2010 fiscal year. BSI (UK) is evaluating Ingen's CE Mark application, and we expect to achieve the CE Mark during our first quarter of 2010. The CE Mark and the ISO 13485:2003 certification allows the company to fulfill export orders for China, Canada, Australia and the European Communities. The People's Republic of China is also currently evaluating the company's ISO Registration, and it is expected that its products will reach the Chinese market by July 2010.

 

During our fourth quarter, Ingen secured a signed GPO contract with MediGroup Physician Services; one of the nation's largest GPO for the alternate site marketplace, which consists of specialty physicians and surgery centers. MediGroup provides its customers with the purchasing power that is traditionally reserved for hospitals, while enabling participating manufacturers and distributors to deliver products and services to a focused demographic. A Group Purchasing Organization (GPO) is an entity that helps health care providers - such as hospitals, nursing homes and home health agencies - realize cost-savings and efficiencies by aggregating purchasing volume and using that leverage to negotiate discounts with manufacturers, distributors and other vendors. There are more than 600 organizations in the United States that participate in some form of group purchasing. The company is negotiating several other GPO contracts to grow its sales in the hospital commercial market, and expects to see revenues from MediGroup during the first quarter-2010.

 

Ingen is at its reflex point and on the verge of tremendous growth, after enduring a number of regulatory and economic obstacles. In the face of economic headwinds, the company obtained both FDA and ISO Certification and launched several new and inspiring medical products in the respiratory market. As a result of this success, we have attracted many investors and new shareholders. The company's product line is essentially recession-proof and continues to gain momentum in the respiratory markets. Ingen has made important changes to foster a growth culture with a clear vision for the future. With these successes and changes, the company has undergone a restructuring in order to align their incentives with that of their shareholders. The company is now keenly focused on growth, open communication, and leadership by example, as it works diligently to expand its sales and deliver shareholder value.

 

Ingen has developed a global perspective on the markets in which it competes. First, the company conducted a thorough market study for our products with InTouch Life Science Corporation, while at the same time filing patents and trademarks for our proprietary technology; second, the company properly registered their products with the FDA and qualified the products for FDA export; third, the company hired Emergo Group, a recognized global consulting firm that assisted us with the ISO 13485 Certification, CE Mark and distribution partners in order to comply with the world markets for distribution of their medical products; and finally, the company hired KGMA Business Solutions, a leading consulting firm to prepare and file their GSA Contract, as well as develop government contracts with the VA Hospitals and Department of Defense. More important, Ingen has lowered their production costs for their products, increased their margins and the margins of their distributors, while keeping a competitive edge on pricing their products in today's challenging medical markets.

 

"I continue to believe that our inspiration comes from many sources - our shareholders, customers and consumers, as well as our critics. Our staff and consulting team have a passion for what they do that ignites this inspiration every day, everywhere we do business. We remain fresh, relevant and original by knowing what to change without changing what we know. We are asking more questions, listening more closely, and collaborating more effectively with our distribution partners and strategic consultants to give our customers the product they need, and provide our shareholders with the results that they deserve and expect," said Ingen CEO Scott Sand.

 

http://www.ingen-tech.com/

 

 

http://www.smartnasalcannula.com/

 

 

http://www.ingenpulseoximeter.com/

 

 

Ingen Technologies specializes in marketing, developing and distributing of medical technology products. Products designed by Ingen are providing effective and reliable solutions to medical professionals and patients worldwide while also enabling companies like Lincare Holdings (LNCR) and Cardinal Health, Inc. (CAH) the ability to meet a low cost minimization point which could help save the industry billions of dollars and improve patient quality of life -- a value proposition that is impossible to ignore for very long!

[greengiant]

Ingen Unveils the New SMART Nasal Cannula at Alpha-1
Ingen at the Alpha-1 Association National Conference in Orlando, Florida


           Buzz up! 0 Print..Companies:Ingen Technologies, Inc..Related Quotes
Symbol Price Change
IGNT.PK 0.0004 0.0000


{"s" : "ignt.pk","k" : "a00,a50,b00,b60,c10,g00,h00,l10,p20,t10,v00","o" : "","j" : ""} Press Release Source: Ingen Technologies, Inc. On Monday June 14, 2010, 8:15 am

Ingen Technologies, Inc. (IGNT), Manufacturer of the New SMART Nasal Cannula for the Home Care Provider Market and Hospital Market, is Featured Side-by-Side Mid and Large Cap Companies Such as Baxter (BAX) at the Alpha-1 19th Annual National Education Conference



YUCAIPA, Calif., June 14, 2010 (GLOBE NEWSWIRE) -- Ingen Technologies, Inc. (Pink Sheets:IGNT - News), a medical device manufacturer with an emerging new medical product line for the respiratory market worth an estimated $4 billion in the U.S. and $8 billion globally, unveiled their new SMART Nasal Cannula in Orlando-Florida last week at the Alpha-1 19th Annual National Education Conference.



The Alpha-1 Association is a member-based not-for-profit organization dedicated to identifying those affected by Alpha-1 Antitrypsin Deficiency (Alpha-1) and to improve the quality of their lives through support, education, advocacy and to encourage participation in research. Alpha-1-Antitrypsin Deficiency (Alpha-1) is a genetic disorder that can cause liver and lung disease in children and adults.



"We were very pleased to be an exhibitor and sponsor at this year's conference for Alpha-1. There are hundreds of patient members of the Alpha-1 Association, and many of them attended the conference, along with clinicians and physicians from around the globe. Our new SMART Nasal Cannula was featured and well accepted by the attendees. It is our goal to pick up the pace in supporting the various associations that support patients who require home oxygen therapy and the use of our products," stated Scott R. Sand, CEO and Chairman of the Board.

[STOCKSEEKER]

News out on this one again this morning. Awesome volume coming in on this one today. I expect to see alot more from the company this week and weeks to come. Were at a great entry point here. There is rumors of the company announcing contracts after the bell. Hope to see that one hit the wire soon. Good luck to you all

[justin76]

IGNT a medical device manufacturer with an emerging new medical product line for the respiratory market. Yesterdays close +25.00% Vol. 305 Million! Stock should continue its run this week! imo http://stockcharts.com/h-sc/ui?s=IGNT&p=D&b=5&g=0&id=p10380279369

[greengiant]

Ingen Debuts Medical Products to U.S. Army
KGMA Business Solutions Tradeshow Line-Up


Share
retweet
EmailPrint..Companies:Ingen Technologies, Inc..Related Quotes
Symbol Price Change
IGNT.PK 0.0003 0.0000


{"s" : "ignt.pk","k" : "a00,a50,b00,b60,c10,g00,h00,l10,p20,t10,v00","o" : "","j" : ""} Press Release Source: Ingen Technologies, Inc. On Wednesday July 7, 2010, 8:00 am EDT

YUCAIPA, Calif., July 7, 2010 (GLOBE NEWSWIRE) -- Ingen Technologies, Inc. (Pink Sheets:IGNT - News), a medical device manufacturer with an emerging new medical product line targeting the $8B respiratory market, announced today that the company's strategic government contract consultant, KGMA Business Solutions, has scheduled two major tradeshows for August and September, 2010.



Ingen will debut its new Smart Nasal Cannula on August 10-11, 2010 at the 13th Annual Force Health Protection Conference (FHP) in Phoenix, Arizona; and again on September 8th, 2010 at the Fort Detrick Vendor Day in Frederick, Maryland.



The FHP Conference provides a venue to educate attendees about health promotion, disease and injury prevention, health risks from occupational and environmental health threats and zoonotic diseases, and related preventive medicine and public health topics in garrison and deployed settings. This event will include representatives from DoD, VA and other U.S. Government agencies, academia, industry partners, and allied nations.



Fort Detrick Vendor Day will host the Defense Medical Materiel Program Office (DMMPO), U.S. Army Medical Materiel Agency (USAMMA), the Naval Medical Logistics Command (NAVMEDLOGCOM), the Air Force Medical Evaluation Support Activity (AFMESA), the Air Force Medical Logistics Office (AFMLO), and the U.S. Marine Corp Systems Command. The focus of this year's venue is on "new" products.



"KGMA Business Solutions has structured an aggressive tradeshow schedule while they work at closing $1.4M in government purchases," said Chairman and CEO Scott R. Sand. "Our marketing program is targeted for $11M in the 2010 fiscal year sales."



http://www.eventsinamerica.com/events/13th_annual_force_health_protection_conference/ev4a9c3043dc273/



http://www.detrick.army.mil/services/vendorday.cfm



http://www.ingen-tech.com/


http://www.smartnasalcannula.com/


http://www.ingenpulseoximeter.com/


About Ingen:



Ingen is an ISO Certified medical device manufacturer with an emerging new medical product line for the respiratory market worth an estimated $4 Billion in the U.S., and $8 billion globally. The company introduced Oxyview into the respiratory market in late 2007 after securing U.S. and Foreign Patents and a successful registration with the Food & Drug Administration. The company is establishing domestic and global distribution with manufacture representative organizations, and OEM partners. In 2009 the SMART Nasal Cannula using Oxyview Technology was introduced as the world's first oxygen cannula with an in-line pneumatic oxygen flow meter. In 2010 the company introduced its new INGEN Pulse Oximeter. The Oxyview product line is available to the home care markets, commercial medical markets, aviation, automotive, and government sources. The company is licensed with the Department of Health and Human Services, and manufactures its products in the State of California. With approximately 32 million US patients with Chronic Obstructive Pulmonary Disease (COPD), and 600 million patients worldwide, Ingen Technologies is now the largest manufacturer of in-line gravity-independent oxygen flow meters.



The Ingen Technologies, Inc. logo is available at http://www.globenewswire.com/newsroom/prs/?pkgid=2472

[setravis]

greengiant,
If I'm not mistaken, I do believe you also post under the user name STOCKSEEKER
That's a no no, in my book you should only have a need to post under one user name.
By using various different names makes me assume that you are just up to no good